Ardelyx (ARDX) Capital Expenditures (2013 - 2026)
Ardelyx (ARDX) posted Capital Expenditures of $69000.0 for Q1 2026, down 80.89% on a QoQ basis from $361000.0 in Q4 2025, and down 78.77% year-over-year from $325000.0 in Q1 2025.
Ardelyx (ARDX) Capital Expenditures (2013 - 2026) Analysis & Trends
Ardelyx's Capital Expenditures history runs 14 years deep, the most recent figure standing at $69000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 78.77% year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 4.22% YoY) and the FY2025 annual result came in at $1.5 million, up 47.58% from the prior year.
- Capital Expenditures was $69000.0 for Q1 2026 at Ardelyx, down from $361000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $650000.0 in Q2 2025 and bottomed at $14000.0 in Q1 2023.
- A 5-year average of $212214.3 and a median of $143500.0 in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures jumped 1279.07% — and 2026, when it sank 78.77%.
- Ardelyx's Capital Expenditures stood at $55000.0 in 2022, then retreated by 21.82% to $43000.0 in 2023, then soared by 1279.07% to $593000.0 in 2024, then sank by 39.12% to $361000.0 in 2025, then slumped by 80.89% to $69000.0 in 2026.
- Business Quant data shows ARDX's Capital Expenditures at $69000.0 in Q1 2026, $361000.0 in Q4 2025, and $156000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Dec 31, 2025 | 361,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Sep 30, 2025 | 156,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Dec 31, 2024 | 593,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Jun 30, 2024 | 131,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Dec 31, 2023 | 43,000.00 |
| Dec 31, 2023 | 43,000.00 |